thank stand time would like welcome everyone iqvia first quarter earn conference call operator instruction reminder call record thank would like turn call child senior vice president investor relation corporate communication child please begin conference child senior vice president investor relation corporate communication thank good morning everyone thank join first quarter earn call today chairman chief executive officer executive vice president chief financial officer executive vice president general counsel senior vice president financial plan analysis associate director investor relation today reference presentation visible call webcast presentation also available follow call event presentation section iqvia investor relation website iqvia begin would like caution listener certain information discuss management conference call include forward look statement actual result differ materially state imply forward look statement risk uncertainty associate company business discuss company file security exchange commission include annual report form subsequent file addition certain financial measure call consider supplement substitute financial measure prepare accordance reconciliation measure comparable measure include press release conference call presentation would like turn call chairman chairman chief executive officer thank good morning everyone thank join today first quarter result iqvia strong financial result quarter despite broader macro environment note regard first tragic situation think concern begin around safety employee patient support affect ongoing event actively support employee family evacuation support relocation service financial assistance example accelerate bonus payment actually continue employee regardless ability perform work addition iqvia capability utilize help support result refugee crisis example refugee enter surround country medicine prescription medical professional country seek identify convert product information prescription local equivalent help establish free online service medical professional search product name active ingredient strength tool generate list match product whichever local country around also work closely customer supplier clinical site across region ensure continuity site clinical trial ensure course client able continue support effective delivery medicine vulnerable patient region depend medicine provide support ensure trial patient begin receive treatment remain treatment protocol establish direct patient shipment investigational medical product patient call center order ensure patient care continue guide ethical concern ensure safety patient already clinical trial utilize global logistics procurement infrastructure facilitate movement investigational medical product sample country minimize potential adverse impact patient care study start early phase country redirect patient recruitment country base consultation customer even though little overall revenue approximately global patient recruitment come operational disruption describe financial impact incorporate update guidance another focus area investor quarter know emerge biopharma fund environment receive number question topic since earn release address multiple forum however linger question topic want take opportunity reiterate comment specific focus fund environment beyond company exposure segment start state concern fund environment overstate want support four point number industry observe slowdown public fund compare record level private venture capital market continue strong fund first quarter third highest ever national venture capital association also observe firm large amount cash strong fund cycle number reduction fund market contract large pharma company often step acquisition activity company frankly benefit long stand relationship customer fact recent acquisition pharmaceutical illustrate point number three history tell fund slow significant effect business example follow last fund slowdown iqvia biotech unit interruption business revenue growth unusual increase finally number four look either pipeline activity simply slowdown unusual activity unusual delay decision make fact quarter overall dollar year year dollar broader industry continue show strength clinical trial start first quarter compare last year increase oncology trial start therapeutic area know predominantly sponsor focus exposure segment specifically commercial zero revenue vulnerable expose fund environment want make another four point number march commercial represent total backlog number overall dollar quarter come commercial number three exposure commercial iqvia minimal also want point underline process take commercial extremely rigorous thorough process include example review client cash balance payment history viability quality science course progress clinical development differently every knock door molecule think interest make backlog number four would simply remind exposure primarily impact segment approximately iqvia total company revenue come commercial business know virtually zero commercial exposure commercial side comment background delve first quarter result revenue first quarter grow report basis constant currency million beat midpoint guidance range drive strong operational performance across three segment course partially offset foreign exchange headwind compare prior year exclude relate work year core business grow constant currency organic basis provide additional detail remark include adjust number three segment first quarter adjust grow reflect revenue growth ongoing productivity initiative first quarter adjust dilute grow midpoint guide beat come operational improvement provide update business start commercial technology side speak familiar iqvia connect intelligence framework leverage advance analytics technology domain expertise across entire clinical commercial portfolio critical support emerge need pharma industry want give recent example capability deploy quarter enter multi year agreement development commercialization indication rare disease product currently approve treatment rare autoimmune disorder affect muscle collaboration incorporate iqvia connect intelligence support clinical development real world evidence regulatory commercial support accelerate development product potential treatment severe autoimmune disease expand globally excite product upside potential currently approve treat indication potential indication plus drug already launch plan launch next year another example client select iqvia integrate capability solve complex problem pharma client recently select iqvia vigilance platform regulatory information management technology area real headache client technology solution simplify streamline process benefit technology integrate inaudible capability automation labor heavy activity easy implementation date client adopt solution within safety regulatory quality suite technology real world evidence sure select support data analysis real world network strategic initiative major iqvia draw proprietary technology method deep scientific operational expertise help deepen relationship healthcare provider site across move clinical technology iqvia continue lead industry clinical trial solution integrate technology service capability utilize third full service trial globally date recruit patient across country cover indication whether traditional trial demand suite digital critical technology offer continue increase first quarter date client adopt module within orchestrate clinical technology suite since launch module example clinical trial payment solution technology ensure accurate timely transparent investigator payment process driver site sponsor satisfaction pharma client select iqvia payment technology solution trial include major award quarter sponsor migrate entire payment ecosystem across several legacy platform technology scale technology migration largest kind industry encompass clinical study across phase site globally beyond client highlight overall business continue strong momentum quarter deliver billion business include past throughs include record quarter billion service book result first quarter contract book bill ratio exclude throughs include throughs last month contract book bill ratio exclude include contract backlog grow year year record billion march result next month revenue backlog increase billion grow year strong positive momentum across business regardless choppy macro environment final note iqvia name overall reputation clinical trial site around world central award global site benchmark survey deal rigorous independent survey highly respect industry investigator trial coordinator research nurse clinical professional represent clinical trial site around world rank score across performance relate attribute proud select name overall reputation specifically receive high mark especially high mark comprehensive trial direct patient recruitment therapeutic clinical regulatory technology expertise turn detail financial performance executive vice president chief financial officer thank good morning everyone start review revenue first quarter revenue grow report basis constant currency quarter relate revenue approximately million versus first quarter base business exclude relate work year last organic growth constant currency technology analytics solution revenue first quarter report constant currency exclude relate work organic growth constant currency analytics solution solution first quarter revenue actual rate constant currency exclude relate work organic growth constant currency approximately consistent expectation contract sale medical solution first quarter revenue million grow report constant currency exclude relate work organic growth constant currency single digit move adjust million first quarter represent growth report basis first quarter income million year year dilute earn share dollar year year adjust income million quarter year year adjust dilute earn share grow already review solution deliver another outstanding quarter business backlog march stand record billion increase year year month revenue backlog increase year year billion would note backlog month revenue number quote affect rate quarter lower otherwise would strengthen dollar quarter move balance sheet first quarter cash flow operation million capex million result free cash flow million reminder free cash flow first quarter year affect time annual bonus payment march cash cash equivalent total million gross debt result debt leverage ratio march time trail month adjust quarter repurchase million share slightly billion share repurchase authorization remain current program would group guidance full year expectation remain unchanged organic revenue growth exclude relate work teen constant currency since fluctuation cause incremental full year revenue headwind million yesterday rate addition currently estimate revenue disruption crisis million million range accordingly update revenue guidance range reflect factor full year expect revenue represent year year growth constant currency report compare reminder revenue guidance provide call absorb million headwind versus initial guidance provide analyst investor conference project revenue growth include basis point contribution activity despite macro factor affect revenue guidance reaffirm full year adjust adjust guidance range provide fourth quarter earn call include absorb earn impact lose revenue remain salary assistance provide employee accordingly continue expect adjust represent year year growth continue expect adjust dilute year year growth full year guidance range assume foreign currency rate yesterday remain effect balance year move second quarter guidance remind first half last year represent relate revenue result second quarter toughest year year compare term revenue second quarter revenue expect represent growth constant currency basis report basis exclude exclude relate work expect organic revenue growth constant currency teen consistent actuals project full year revenue growth adjust expect million million adjust dilute expect grow summarize deliver strong first quarter result bottom line strong first quarter base business maintain teen organic growth constant currency exclude relate work double digit growth basis inaudible book excuse business record largest ever quarter service book contract backlog exceed billion first time rise year year billion expect convert revenue next month maintain leverage ratio time month adjust trail basis finally importantly despite turmoil around remain confident outlook accordingly maintain full year profit guidance hand back operator session